Parkinson's Disease Care in Latvia: Insights from Patients and Neurologists Poster

Parkinson's Disease Care in Latvia: Insights from Patients and Neurologists


D
Dr. Paula Abola Corresponding Author
Published: 09/06/2026
Share:

Parkinson’s Disease (PD) management requires timely access to specialist care, medication, rehabilitation services, and ongoing patient support. Although regional disparities in healthcare access have been reported internationally, little empirical evidence has examined how these challenges affect people living with PD in Latvia.


This pilot study explored regional differences in PD management from both patient and neurologist perspectives. A cross-sectional online survey was completed by 50 individuals living with PD and 55 neurologists practicing across Latvia. The survey examined access to specialist services, travel burden, waiting times, medication reimbursement, non-pharmacological support, telemedicine, and perceived barriers to care.


Findings revealed significant regional differences in travel distance to neurologist services, appointment accessibility, availability of multidisciplinary care, medication reimbursement, and access to advanced treatment options. Patients outside Riga reported greater challenges accessing specialist services and rehabilitation support. Neurologists identified long waiting times, limited funding, restricted access to advanced therapies, and shortages of multidisciplinary resources as major system-level barriers. Both groups highlighted the need for expanded reimbursement, improved regional service availability, stronger multidisciplinary collaboration, and greater use of telemedicine.


The findings suggest that geographical location continues to influence access to PD care in Latvia. Strengthening multidisciplinary networks, improving reimbursement pathways, supporting telemedicine initiatives, and enhancing regional healthcare capacity may contribute to more equitable and patient-centered PD management nationwide.


Scroll to read the preview. Download for the complete document.

Abola, P., & Wolden, M. (2026). Disparities in neurological management for Parkinson’s disease in Latvia: Pilot study evidence. Equity Neuroscience, 2(1), 100023. https://doi.org/10.1016/j.neuros.2026.100023


Schneider, R. B., & Biglan, K. M. (2017). The promise of telemedicine for chronic neurological disorders: The example of Parkinson’s disease. The Lancet Neurology, 16(7), 541–551. https://doi.org/10.1016/S1474-4422(17)30167-9


Weise, D., Claus, I., Dresel, C., Kalbe, E., Liepelt-Scarfone, I., Lorenzl, S., Redecker, C., & Urban, P. P. (2024). Multidisciplinary care in Parkinson’s disease. Journal of Neural Transmission, 131(10), 1217–1227. https://doi.org/10.1007/s00702-024-02807-w


World Health Organization. (2024). Latvia aims to improve people’s access to medicines, in line with WHO recommendations. World Health Organization. https://www.who.int


World Health Organization. (2022). Parkinson disease: A public health approach. World Health Organization. https://www.who.int


van der Marck, M. A., Munneke, M., Mulleners, W. M., Hoogerwaard, E. M., Borm, G. F., Overeem, S., Bloem, B. R., & Nijkrake, M. J. (2013). Integrated multidisciplinary care in Parkinson’s disease: A non-randomised, controlled trial (IMPACT). The Lancet Neurology, 12(10), 947–956. https://doi.org/10.1016/S1474-4422(13)70196-0

D
Dr. Paula Abola Corresponding Author

Affiliation

Faculty of Business and Management Studies, European International University, 59 Rue Lamarck, 75018 Paris, France

0
Downloads
5
Views

Metrics are updated in real time as the article is accessed and downloaded.

Comments

Leave a Comment

Share this Article

Back to Publications
Scroll to Top